← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

F

$ Value

$255K

Shares

3,608

Price

$71

Filed

Feb 24

Insider

Name

LaBrosse Nicole

Title

SVP, CHIEF FINANCIAL OFFICER

CIK

0001910662

Roles

Officer

Transaction Details

Transaction Date

2026-02-23

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,494

Footnotes

The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. | The reported disposition of 3,608 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. | This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

Filing Info

Accession No.

0001159036-26-000029

Form Type

4

Issuer CIK

0001159036

LaBrosse Nicole's History

Date Ticker Type Value
2026-02-23 HALO M $0
2026-02-23 HALO F $255K
2026-02-23 HALO M $0
2026-02-20 HALO M $0
2026-02-20 HALO F $204K
2026-02-20 HALO M $0
2026-02-16 HALO M $0
2026-02-16 HALO F $218K
2026-02-16 HALO M $0
2026-02-16 HALO F $228K

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$10.6M 2026-04-06
Snyder Mark Howard
SVP, CHIEF LEGAL OFFICER
2026-02-23
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
2026-02-23
Caudill Cortney
SVP, CHIEF OPERATING OFFICER
$2.0M 2026-03-10